Skip to content
Back to Guavy Wire
Crypto

Swiss Medical Network Posts 18.8% H1 EBITDAR Surge to CHF 94 Million

Instruments
DAR
Share

AEVIS Victoria SA, the parent company of Swiss Medical Network (SMN), has reported an impressive increase in its first-half EBITDAR. The metric rose by a significant 18.8% to CHF 94 million during the period ending June 30, 2026.

This growth marks a notable achievement for SMN, which provides medical services and solutions across Switzerland. While specific details about the drivers behind this increase are not provided in the report, it is clear that AEVIS Victoria SA's strategy has yielded positive results for its subsidiary.

The Swiss Medical Network's improved EBITDAR performance will likely be a welcome development for investors and stakeholders. As the healthcare industry continues to evolve, companies like SMN must adapt to changing market conditions while maintaining their commitment to quality services.

More on Crypto

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc